BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 18417366)

  • 41. Neural tube defects: prevalence, etiology and prevention.
    Kondo A; Kamihira O; Ozawa H
    Int J Urol; 2009 Jan; 16(1):49-57. PubMed ID: 19120526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physicians' knowledge and attitudes regarding periconceptional folic acid supplementation: a survey in Southern Israel.
    Abu-Hammad T; Dreiher J; Vardy DA; Cohen AD
    Med Sci Monit; 2008 May; 14(5):CR262-267. PubMed ID: 18443550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy outcome in ethanol-treated mice with folic acid supplementation in saccharose.
    Yanaguita MY; Gutierrez CM; Ribeiro CN; Lima GA; Machado HR; Peres LC
    Childs Nerv Syst; 2008 Jan; 24(1):99-104. PubMed ID: 17619885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of folic acid cooperated with soybean isoflavone on the neural tube defects pregnant rats].
    Xiao R; Liang J; Li XH; Zhao HF; Niu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):400-5. PubMed ID: 15569513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Does folic acid have effects on other health problems than neural tube defects?].
    Staff AC; Holven K; Løken EB; Sygnestveit K; Vollset SE; Smeland S
    Tidsskr Nor Laegeforen; 2005 Feb; 125(4):438-41. PubMed ID: 15742017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China.
    Chen G; Song X; Ji Y; Zhang L; Pei L; Chen J; Liu J; Li C; Zheng X
    Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):592-6. PubMed ID: 18634013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonspecific stimulation of the maternal immune system. I. Effects On teratogen-induced fetal malformations.
    Holladay SD; Sharova L; Smith BJ; Gogal RM; Ward DL; Blaylock BL
    Teratology; 2000 Dec; 62(6):413-9. PubMed ID: 11091363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice.
    Fukushima R; Kanamori S; Hirashiba M; Hishikawa A; Muranaka RI; Kaneto M; Nakamura K; Kato I
    Reprod Toxicol; 2007; 24(3-4):310-6. PubMed ID: 17604599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital diaphragmatic hernia after exposure to a triple retinoic acid antagonist during pregnancy.
    Cipollone D; Cozzi DA; Businaro R; Marino B
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):389-392. PubMed ID: 21107276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fortification of food with folic acid diminishes the number of neural tube defects].
    Brouwer IA
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):185-6. PubMed ID: 18320941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of ochratoxin A-induced neural tube defects by folic acid in the genetic polydactyly/arhinencephaly mouse, Pdn/Pdn.
    Katagiri R; Kurome M; Teshima Y; Ueta E; Naruse I
    Congenit Anom (Kyoto); 2007 Sep; 47(3):90-6. PubMed ID: 17688467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotine-induced embryonic malformations mediated by apoptosis from increasing intracellular calcium and oxidative stress.
    Zhao Z; Reece EA
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):383-91. PubMed ID: 16193507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
    Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of congenital malformations by means of folic acid - insurmountable problems due to the German penal code and German drug legislation when preparing a preconceptional model in Saxony-Anhalt].
    Rösch C; Steinbicker V; Robra BP; Kolbe M; Heinrich C
    Gesundheitswesen; 2001 Jul; 63(7):430-4. PubMed ID: 11507668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice.
    Sugimura Y; Murase T; Kobayashi K; Oyama K; Hayasaka S; Kanou Y; Oiso Y; Murata Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):287-94. PubMed ID: 19242917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.
    Wlodarczyk B; Spiegelstein O; Gelineau-van Waes J; Vorce RL; Lu X; Le CX; Finnell RH
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):238-46. PubMed ID: 11749123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite.
    Finnell RH; Bennett GD; Karras SB; Mohl VK
    Teratology; 1988 Oct; 38(4):313-20. PubMed ID: 3149038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Homocysteine interference in neurulation: a chick embryo model.
    Afman LA; Blom HJ; Van der Put NM; Van Straaten HW
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):421-8. PubMed ID: 12962286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Severe bone malformations in fetal valproic acid disease].
    Lorenzo Sanz G; Serna Saugar C; Quintana Castilla A; Lozano Giménez C; Aparicio Meix JM
    An Esp Pediatr; 1993 Jul; 39(1):19-21. PubMed ID: 8363144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.